Farm Comunitarios. 2025 Feb 09;17(2):15-20. doi: 10.33620/FC.2173-9218.(2025).10

Adherence Improvement in Transplant Patient after Being Included in Medication Reconditioning Service

Sánchez-Calero ME1, Pérez-Sánchez D2
1. Assistant Pharmacist in Pharmacy Lda. Delia Pérez Sánchez 2. Pharmacist in Pharmacy Lda. Delia Pérez Sánchez
Sánchez-Calero ME, Pérez-Sánchez D. Adherence Improvement in Transplant Patient after Being Included in Medication Reconditioning Service. Farm Comunitarios. 2025 Feb 09;17(2):15-20. doi: 10.33620/FC.2173-9218.(2025).10
Abstract : 

Male patient, 75 years of age, pluripathological and polymedicated. He underwent a liver transplant in 2006 so he was followed up by two hospitals in different provinces (Madrid and Castilla-La Mancha) which made the review even more difficult.

In the last few months, the pharmacists have noticed various discrepancies when dispensing his electronic prescriptions. We decided to offer him the Monitored Dosage Systems (MDS). He is a vulnerable patient given his pathologies and meets all the requirements to include him in the program.

In a first interview, the patient is confused with the medication, he brings us full boxes of some medications and others are missing, suspecting that he does not follow the dosage indicated by the doctor, with the consequent lack of adherence to treatment.

After the medication review, we found different Drug-Related Problems (DRPs): duplicity and dosage, regimen and/or inadequate duration. We contacted the primary care physician (GP) and the gastroenterologist to review the prescribed medication.

After 8 months of being included in the MDS service, there has been a positive impact on the patient. He’s health has significantly improved; he has gained weight, decreased the number of medication and improved his therapeutic adherence.

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit 
https://creativecommons.org/licenses/by-nc/4.0/deed.en

Share

-

Related contents

Manual for authors

Journal Information